Using a CNNM3 mutant (D426A) that has lost its capacity to interact with PRL-2 or a small molecule inhibitor of the complex formation between these two proteins, we showed that this interaction is important for breast cancer cell proliferation and tumor growth. Here, CNNM3 is linked to neoplasm.